Department Researches & Publications

Faculty of Pharmacy

Assiut University

Department of Pharmaceutics

Research Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems 
# Title Research Year
41 Performance of simvastatin microsponges as a local treatment for chronic periodontitis – Randomized clinical trial 2021
42 Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo 2021
43 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles 2021
44 Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics 2021
45 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles 2021
46 Development and Evaluation of Letrozole‑Loaded Hyaluronic Acid/Chitosan‑Coated Poly(d,l‑lactide‑co‑glycolide) Nanoparticles 2021
47 Transfersomal Gel Nanocarriers for Enhancement the Permeation of Lornoxicam 2020
48 Electrospun vancomycin-loaded nanofibers for management of methicillin-resistant Staphylococcus aureus-induced skin infections 2020
49 Severe cutaneous adverse drug reactions: Incidence, Clinical Patterns, Causative Drugs and Modalities of Treatment in Assiut University Hospital, Upper Egypt 2020
50 Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19 2020